Hepatitis C News and Research

Latest Hepatitis C News and Research

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

Children need to be up-to-date on immunizations before heading back-to-school

While we prepare our children to go back to school, parents should check and make sure their children are current on all vaccinations before the start of the school year or they may not be able to start on the first day.

17 Aug 2017

Researchers identify role of blood-filtering organs in fighting against viral infections

New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College of Medicine researchers.

17 Aug 2017

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

10 Aug 2017

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

According to a recent announcement made by Public Health England, there is a global shortage of vaccines used against hepatitis B infection. This announcement is followed up by a “prioritisation guidance” which means that persons who are at greatest risk of getting hepatitis B are to be vaccinated on priority if they have not received the vaccine before.

7 Aug 2017

Congress revamps housing program to benefit areas where HIV is spreading

In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

7 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Representatives from the London Assembly and local authorities in the Capital are set to meet with third sector and public health representatives in a roundtable meeting hosted by biopharmaceutical company, AbbVie, on World Hepatitis Day.

3 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Binding Site launches new antigens and antibodies for infectious/contagious diseases

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.

From Binding Site 29 Jul 2017

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown that nearly 70% of the world hepatitis burden is borne by these countries.

27 Jul 2017

Scientists notice shift in transmission mechanism of HEV infections

Hepatitis E gets little press compared to its better-known cousins A, B, and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing. World Hepatitis Day is commemorated on 28 July.

27 Jul 2017

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection.

26 Jul 2017

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments into account.

25 Jul 2017

New report identifies lack of knowledge about heart disease in prison populations

The incarcerated population -- both those currently in prison and those who have been released -- are more susceptible to heart disease than the rest of the country's population. And what we know about the factors that play into this is extremely limited, according to researchers.

25 Jul 2017

Princeton scientists test cell-culture system to aid study of HBV infections

Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections

25 Jul 2017

Relaxed blood donation rules for gay men and sex workers in England and Scotland

Blood donation rules in England and Scotland have been relaxed to allow gay men and sex workers to donate blood, due to more more accurate testing being available. Homosexual men can now donate blood three months after their last sexual activity instead of 12 months as was the rule before. Earlier gay men were banned from donating blood for life

24 Jul 2017

WHO alerts countries to increasing trend of HIV drug resistance

WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries.

21 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

Pork products associated with carrying hepatitis E virus in Britain

Children need to be up-to-date on immunizations before heading back-to-school

Researchers identify role of blood-filtering organs in fighting against viral infections

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

Shortage of Hepatitis B vaccine - prioritization of vaccinations announced in UK

Congress revamps housing program to benefit areas where HIV is spreading

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Binding Site launches new antigens and antibodies for infectious/contagious diseases

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

Scientists notice shift in transmission mechanism of HEV infections

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

New report identifies lack of knowledge about heart disease in prison populations

Princeton scientists test cell-culture system to aid study of HBV infections

Relaxed blood donation rules for gay men and sex workers in England and Scotland

WHO alerts countries to increasing trend of HIV drug resistance

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis C News and Research

Latest Hepatitis C News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in